Evidence map›Paper›PMID 22560721›Full record

ArticleMolecular cell2012

Human embryonic stem cells have constitutively active Bax at the Golgi and are primed to undergo rapid apoptosis.

Raluca Dumitru, Vivian Gama, B Matthew Fagan, Jacquelyn J Bower, Vijay Swahari, Larysa H Pevny, Mohanish Deshmukh

Open access · bronzeAbstract read
In one paragraph

Article in Molecular cell, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 109 papers.

0numbers the graph read from it
0cells of the map it votes in
109citing papers in PubMed
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

109 citing papers in PubMed, 161 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. DPPA5A suppresses the mutagenic TLS and MMEJ pathways by modulating the cryptic splicing ofProceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Lysosomal KEMBO reports · 2022
    Article
  20. Review

49 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Raluca DumitruNeuroscience Center, University of North Carolina, Chapel Hill, North Carolina 27599, USA.
Vivian Gama
B Matthew Fagan
Jacquelyn J Bower
Vijay Swahari
Larysa H Pevny
Mohanish Deshmukh
University of North Carolina at Chapel Hill · USUNC Lineberger Comprehensive Cancer Center

Funding

Cytochrome c Degradation: A Mechanism to Restrict Apoptosis in Postmitotic CellsR01GM078366 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DESHMUKH, MOHANISH P · 2006 to 2013
$2.6M
Identifying predictors of racial disparity in treatment and mortality among patients diagnosed with breast cancer in South Carolina and geospatial investigation of breast cancer patient navigationF99CA222722 · NCI · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI BABATUNDE, OLUWOLE ADEYEMI · 2017 to 2018
$80k
NCI NIH HHS F99 CA222722NIGMS NIH HHS GM078366NIGMS NIH HHS R01 GM078366NINDS NIH HHS 5 P30 NS04892
6 · The paper itself

Abstract

Human embryonic stem (hES) cells activate a rapid apoptotic response after DNA damage but the underlying mechanisms are unknown. A critical mediator of apoptosis is Bax, which is reported to become active and translocate to the mitochondria only after apoptotic stimuli. Here we show that undifferentiated hES cells constitutively maintain Bax in its active conformation. Surprisingly, active Bax was maintained at the Golgi rather than at the mitochondria, thus allowing hES cells to effectively minimize the risks associated with having preactivated Bax. After DNA damage, active Bax rapidly translocated to the mitochondria by a p53-dependent mechanism. Interestingly, upon differentiation, Bax was no longer active, and cells were not acutely sensitive to DNA damage. Thus, maintenance of Bax in its active form is a unique mechanism that can prime hES cells for rapid death, likely to prevent the propagation of mutations during the early critical stages of embryonic development.

Indexed as

ApoptosisAcetylationAntigens, Nuclearbcl-2-Associated X ProteinBiological TransportDNA-Binding ProteinsDNA DamageEmbryonic Stem CellsGenes, bcl-2Gene SilencingGolgi ApparatusHumansKu AutoantigenMitochondriaTumor Suppressor Protein p53Antigens, NuclearBAX protein, humanbcl-2-Associated X ProteinDNA-Binding ProteinsKu AutoantigenTumor Suppressor Protein p53Xrcc6 protein, human

Identifiers

PMID22560721
PMCPMC3372694
OpenAlexW1989428846

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.